In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-Lymphocyte functions in chronic hepatitis B leukocytopenic patients

Hepato-Gastroenterology

Volumn 45, Issue 24, 1998, Pages 2295-2302

  Kountouras, Jannis ^a   Boura, Panagiota ^b   Tsapas, George ^b  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

Alanine aminotransferase; Granulocyte macrophage colony stimulating factor; Hepatitis B virus; Interferon; Interleukin; Peripheral blood lymphocytes

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MACROPHAGE; MALE; MONOCYTE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0032412933     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jacyna MR, Thomas HC: Antiviral therapy: hepatitis B. Br Med Bull 1990; 46:368-382.
2. Foster GR, Goldin RD, Hay A, McGarvey MJ, Stark GR, Thomas HC: Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy. Hepatol 1993; 17:757-762.
3. Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kercskemeti K, Bodisky CJ, Campbell CR, Kuhns MC: Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. Ann Intern Med 1988; 109:95-100.
4. Cohard M, Poynard T, Mathurin P, Zarski JP: Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis. Hepatol 1994; 20:1390-1398.
5. Carreno V, Mora I: Combination of recombinant interferon alpha and gamma in treatment of chronic hepatitis B. Lancet 1987; 2:1086-1087.
6. Meller IV, Carreno V, Fowler MJF, Monjardino J, Makinen D, Varghese Z, Sweny P, et al: Acyclovir in hepatitis B antigen positive chronic liver disease: inhibition of viral replication and transient renal impairment with IV bolus administration. J Antimicrob Chemother 1983; 11:223-231.
7. Hoofnagle JH: Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate. J Hepatol 1986; 3(Suppl 2):573-580.
8. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y: Pilot study of ribavirin and interferon-α for chronic hepatitis B. Hepatol 1993; 18:258-263.
9. Janssen HLA, Berk L, Heijtink RA, Ten Kate FJW, Schalm SW: Interferon-α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trial. Hepatol 1993; 17:383-388.
10. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (part II). N Engl J Med 1992; 327:99-106.
11. Martin J, Bosch O, Moladera G, Baltomore J, Quiroga JA, Carreno V: Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. Hepatol 1993; 18:775-780.
12. Martin J, Quiroga JA, Bosch O, Carreno V: Changes in cytokine production during therapy with granulocyte-macrophage colony-stimulating factor in patients with chronic hepatitis B. Hepatol 1994; 20:1156-1161.
13. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (part I). N Engl J Med 1992; 327:28-35.
14. Koff WC, Fann AV: Human tumor necrosis factor-alpha kills herpes virus-infected but not normal cell. Lymphokine Res 1986; 5:215-221.
15. Boyer TD: Portal hypertension and bleeding esophageal varices. In: Zakim D, Boyer TD (Eds.). Hepatology Philadelphia: WB Saunders 1990: pp. 572-615.
16. Knodell RC, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatol 1981; 1:431-435.
17. Bendixen G, Soborg M: A leukocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Danish Med Bull 1969; 16:1-6.
18. Zuckerman S, Ackerman S, Douglas SD: Long-term human peripheral monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunol 1979; 38:401-411.
19. Huber H, Douglas S, Fudenberg HH: The IgG receptor: An immunological marker for the characterization of mononuclear cells. Immunol 1969; 17:7-21.
20. Di Bisceglie AM, Hoofnagle JH: Chronic viral hepatitis. In: Zakim D, Boyer TD (Eds.). Hepatology. Philadelphia: WB Saunders, 1996: pp. 1299-1329.
21. Renault PF, Hoofnagle IH: Side effects of alpha interferon. Semin Liver Dis 1989; 9:273-277.
22. Eckman IR: The liver and hematopoiesis. In: Zakim D, Boyer TD (Eds.). Hepatology. Philadelphia: WB Saunders, 1996: pp. 685-690.
23. Moore MA: Colony stimulating factors. In: Rich RR (Ed.). Clinical immunology. Principles and practice. St. Louis, Missouri: Mosby, 1996: pp. 2019-2029.
24. Perno CF, Yarchoan R, Cooney DA, Hartman NR, Webb DSA, Hao Z, Mitsuya H, et al: Replication of human immunodeficiency virus in monocytes: granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′,3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 1989; 169:933-951.
25. van Furth R: Mononuclear phagocyte and cytokine biology. In: van Furth (Ed.). Hemopoietic growth factors and mononuclear phagocytes. Basel: Karger, 1993: pp. 1-9.
26. Finter NB: Cytokines in the treatment of virus infections. In: Kullberg BJ, van der Meer JWM (Eds.). Biotherapy special issue: Cytokines in the biotherapy of infectious diseases. Netherlands: Kluwer Academic Publ, 1994; 7:151-159.
27. Pergam M, Mitsuyasu RT: Immune regulation: Interferons and interleukins. In: Rich RR (Ed.). Clinical Immunology: Principles and practice. St. Louis-Missouri: Mosby, 1996: pp. 2030-2045.
28. Peters M, Viecling J, Gershwin E, Milich D, Chisari FV, Hoofnagle JH: Immunology and the liver. Hepatol 1991; 13:977-994.
29. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Tod 1996; 17:138-146.
30. Anastassakos Ch, Alexander GJM, Wolstencroft RA, Avery JA, Portmann GS, Panayi DC, Dumonde DC, et al: Interleukin-1 and interleukin-2 activity in Chronic hepatitis B virus infection. Gastroenterol 1988; 94:999-1005.